Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

HICKORY Study Group

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences